BLTP1
Basic information
Region (hg38): 4:122152331-122364167
Previous symbols: [ "KIAA1109" ]
Links
Phenotypes
GenCC
Source:
- Alkuraya-Kucinskas syndrome (Strong), mode of inheritance: AR
- Alkuraya-Kucinskas syndrome (Strong), mode of inheritance: AR
- Alkuraya-Kucinskas syndrome (Strong), mode of inheritance: AR
- Alkuraya-Kucinskas syndrome (Strong), mode of inheritance: AR
ClinVar
This is a list of variants' phenotypes submitted to
- Alkuraya-Kucinskas syndrome (8 variants)
- not provided (6 variants)
- 6 conditions (1 variants)
- Right aortic arch;Hemivertebrae;Renal agenesis (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the BLTP1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 41 | 18 | 60 | |||
missense | 246 | 267 | ||||
nonsense | 12 | |||||
start loss | 0 | |||||
frameshift | 9 | |||||
inframe indel | 3 | |||||
splice donor/acceptor (+/-2bp) | 9 | |||||
splice region | 1 | 5 | 5 | 3 | 14 | |
non coding | 88 | 95 | ||||
Total | 15 | 19 | 254 | 53 | 114 |
Highest pathogenic variant AF is 0.0000329
Variants in BLTP1
This is a list of pathogenic ClinVar variants found in the BLTP1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
4-122170523-C-T | Benign (May 14, 2021) | |||
4-122170662-G-A | BLTP1-related disorder | Likely benign (May 15, 2019) | ||
4-122172862-C-T | Benign (May 13, 2021) | |||
4-122173081-A-C | not specified | Uncertain significance (Aug 02, 2023) | ||
4-122173086-C-T | Alkuraya-Kucinskas syndrome | Uncertain significance (Aug 26, 2022) | ||
4-122173103-T-C | BLTP1-related disorder | Likely benign (Jan 28, 2023) | ||
4-122173160-T-G | BLTP1-related disorder | Benign/Likely benign (Dec 31, 2019) | ||
4-122174374-A-G | Benign (May 12, 2021) | |||
4-122174548-C-T | Benign (May 12, 2021) | |||
4-122174605-AG-A | Pathogenic (May 07, 2022) | |||
4-122174620-A-G | BLTP1-related disorder | Likely benign (Mar 12, 2024) | ||
4-122174642-A-G | not specified | Uncertain significance (Nov 15, 2021) | ||
4-122174734-G-C | Benign (May 12, 2021) | |||
4-122175683-C-T | Benign (May 12, 2021) | |||
4-122175886-A-C | not specified | Uncertain significance (Jul 13, 2022) | ||
4-122175895-C-A | not specified | Uncertain significance (Aug 28, 2023) | ||
4-122186085-T-C | BLTP1-related disorder | Likely benign (Sep 06, 2019) | ||
4-122186087-A-G | not specified | Uncertain significance (Jun 28, 2022) | ||
4-122186105-A-G | not specified | Uncertain significance (Apr 12, 2023) | ||
4-122186116-C-T | Alkuraya-Kucinskas syndrome | Uncertain significance (Dec 18, 2017) | ||
4-122186149-A-G | not specified | Uncertain significance (Aug 01, 2022) | ||
4-122186182-C-T | Uncertain significance (Oct 16, 2020) | |||
4-122186189-T-C | not specified | Uncertain significance (Mar 17, 2022) | ||
4-122187460-C-G | Alkuraya-Kucinskas syndrome • BLTP1-related disorder | Conflicting classifications of pathogenicity (Oct 19, 2020) | ||
4-122187476-A-T | not specified | Uncertain significance (Feb 10, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
BLTP1 | protein_coding | protein_coding | ENST00000264501 | 84 | 210426 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
3.26e-21 | 1.00 | 124620 | 0 | 175 | 124795 | 0.000701 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 6.00 | 1707 | 2.56e+3 | 0.666 | 0.000130 | 32796 |
Missense in Polyphen | 515 | 1106.4 | 0.46547 | 14192 | ||
Synonymous | 1.47 | 816 | 871 | 0.937 | 0.0000428 | 9634 |
Loss of Function | 9.56 | 84 | 246 | 0.342 | 0.0000137 | 3028 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00143 | 0.00143 |
Ashkenazi Jewish | 0.000705 | 0.000695 |
East Asian | 0.000619 | 0.000612 |
Finnish | 0.000420 | 0.000417 |
European (Non-Finnish) | 0.000795 | 0.000777 |
Middle Eastern | 0.000619 | 0.000612 |
South Asian | 0.000670 | 0.000654 |
Other | 0.000998 | 0.000990 |
dbNSFP
Source:
Intolerance Scores
- loftool
- 0.845
- rvis_EVS
- -1.56
- rvis_percentile_EVS
- 3.21
Haploinsufficiency Scores
- pHI
- 0.425
- hipred
- Y
- hipred_score
- 0.685
- ghis
- 0.629
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.249
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- 4932438A13Rik
- Phenotype
- behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); vision/eye phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span);
Gene ontology
- Biological process
- regulation of cell growth;regulation of epithelial cell differentiation;synaptic vesicle endocytosis
- Cellular component
- nucleus;membrane;integral component of membrane;presynapse
- Molecular function
- protein binding